BACKGROUND AND PURPOSE:In parathyroid CT, a noncontrast phase aids discrimination of parathyroid lesions (not iodinecontaining) from thyroid tissue (iodine-containing). When thyroid iodine is pathologically diminished, this differentiation is difficult with standard CT. Because the attenuation of an element is maximal near its K-edge (iodine ¼ 33.2 keV), we hypothesized that dual-energy CT 40-keV virtual monoenergetic images will accentuate thyroid iodine relative to standard images, improving the differentiation of thyroid from parathyroid lesions. Our purpose was to test this hypothesis through quantitative assessment of Hounsfield unit attenuation and contrast-to-noise on dual-energy CT standard (70-keV) and 40-keV noncontrast images.
MATERIALS AND METHODS:For this retrospective study including 20 dual-energy parathyroid CTs, we used an ROI-based analysis to assess the attenuation of thyroid tissue, parathyroid lesions, and sternocleidomastoid muscle as well as corresponding contrast-to-noise on standard and 40-keV noncontrast images. Wilcoxon signed rank tests were performed to compare differences between 70 and 40 keV.RESULTS: Absolute and percentage increases in attenuation at 40 keV were significantly greater for thyroid gland than for parathyroid lesions and sternocleidomastoid muscle (P , .001 for all). Significant increases in the contrast-to-noise of thyroid relative to parathyroid lesions (median increase, 0.8; P , .001) and relative to sternocleidomastoid muscle (median increase, 1.3; P , .001) were observed at 40 keV relative to 70 keV.CONCLUSIONS: Forty-kiloelectron volt virtual monoenergetic images facilitate discrimination of parathyroid lesions from thyroid tissue by significantly increasing thyroid attenuation and associated contrast-to-noise. These findings are particularly relevant for parathyroid lesions that exhibit isoattenuation to the thyroid on parathyroid CT arterial and venous phases and could, therefore, be missed without the noncontrast phase.ABBREVIATIONS: CNR ¼ contrast-to-noise ratio; DECT ¼ dual-energy CT; IQR ¼ interquartile range; VMI ¼ virtual monoenergetic images P arathyroid 4D-CT is a powerful tool for localizing abnormal parathyroid tissue in the setting of primary hyperparathyroidism. 1 Localization of a single adenoma facilitates minimally invasive parathyroidectomy and its associated benefits, 2,3 whereas localization of multigland disease aids bilateral neck exploration. The optimal number of CT phases is undetermined, but the most commonly used protocol involves 3 CT acquisitions of the neck and upper chest, including noncontrast, arterial, and venous phases. 4 Parathyroid lesions, exophytic thyroid nodules, and lymph nodes may appear morphologically identical on CT. 5 Although the